Fertility-sparing surgery is safe for most with epithelial ovarian cancerDecember 16, 2019Gynecologic Cancer
CTS5 score partially validated for predicting late distant breast cancer recurrencesDecember 16, 2019Breast Cancer
Zanubrutinib achieved high response rate in del(17p) CLL cohortDecember 16, 2019Leukemia, Myelodysplasia, Transplantation
Some MCL patients can safely stop venetoclax-ibrutinib, study suggestsDecember 14, 2019Lymphoma & Plasma Cell Disorders
KTE-X19 produces highest response rate in MCL subgroupDecember 14, 2019Lymphoma & Plasma Cell Disorders
Blinatumomab instead of chemo in young patients with relapsed ALLDecember 13, 2019Leukemia, Myelodysplasia, Transplantation
‘Real-world’ data show CAR T therapies are cost effectiveDecember 13, 2019Immuno-oncologyImmunotherapyPractice Management
An off-the-shelf drug to rival CAR T cells: ‘very exciting’December 13, 2019Lymphoma & Plasma Cell DisordersImmuno-oncologyImmunotherapy
Oral azacitidine: First maintenance therapy for AMLDecember 13, 2019Leukemia, Myelodysplasia, Transplantation
TNBC: Adding capecitabine boosts disease-free survival in prospective trialDecember 13, 2019Breast Cancer
